Insider Transactions in Q2 2021 at Cara Therapeutics, Inc. (CARA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2021
|
Jeffrey L. Ives |
SELL
Open market or private sale
|
Direct |
2,520
-14.08%
|
$32,760
$13.05 P/Share
|
|
Jun 07
2021
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
2,304
-12.52%
|
$29,952
$13.04 P/Share
|
|
Jun 07
2021
|
Martin Vogelbaum |
SELL
Open market or private sale
|
Direct |
8,640
-30.0%
|
$112,320
$13.05 P/Share
|
|
Jun 03
2021
|
Harrison M Bains Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+26.09%
|
-
|
|
Jun 03
2021
|
Jeffrey L. Ives |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+28.69%
|
-
|
|
Jun 03
2021
|
Christopher Posner PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+28.13%
|
-
|
|
Jun 03
2021
|
Susan Ph.D. Shiff |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+50.0%
|
-
|
|
Jun 03
2021
|
Martin Vogelbaum |
BUY
Grant, award, or other acquisition
|
Direct |
14,400
+33.33%
|
-
|
|
Apr 21
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-6.44%
|
$81,000
$27.63 P/Share
|